121 related articles for article (PubMed ID: 14659769)
1. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling.
Kameda K; Matsunaga T; Abe N; Hanada H; Ishizaka H; Ono H; Saitoh M; Fukui K; Fukuda I; Osanai T; Okumura K
Eur Heart J; 2003 Dec; 24(24):2180-5. PubMed ID: 14659769
[TBL] [Abstract][Full Text] [Related]
2. Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
Fujiwara T; Saito S; Osanai T; Kameda K; Abe N; Higuma T; Yokoyama J; Hanada H; Fukui K; Fukuda I; Okumura K
Eur J Pharmacol; 2008 Oct; 594(1-3):146-51. PubMed ID: 18703045
[TBL] [Abstract][Full Text] [Related]
3. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
Matsunaga T; Abe N; Kameda K; Hagii J; Fujita N; Onodera H; Kamata T; Ishizaka H; Hanada H; Osanai T; Okumura K
Int J Cardiol; 2005 Nov; 105(2):203-8. PubMed ID: 16243114
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.
Mallat Z; Philip I; Lebret M; Chatel D; Maclouf J; Tedgui A
Circulation; 1998 Apr; 97(16):1536-9. PubMed ID: 9593557
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Fujiwara T; Matsunaga T; Kameda K; Abe N; Ono H; Higuma T; Yokoyama J; Hanada H; Osanai T; Okumura K
Heart Vessels; 2007 Sep; 22(5):303-9. PubMed ID: 17879021
[TBL] [Abstract][Full Text] [Related]
6. Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling.
Tambara K; Fujita M; Nagaya N; Miyamoto S; Iwakura A; Doi K; Sakaguchi G; Nishimura K; Kangawa K; Komeda M
Heart; 2002 Mar; 87(3):242-6. PubMed ID: 11847163
[TBL] [Abstract][Full Text] [Related]
7. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Wang W; Zhang HT; Yang XL
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
[TBL] [Abstract][Full Text] [Related]
8. Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction.
Yokota T; Tomita H; Mori Y; Kudo T; Hiraga H; Suto N; Higuma T; Abe N; Hanada H; Osanai T; Okumura K
J Cardiovasc Pharmacol; 2014 Jun; 63(6):528-32. PubMed ID: 24709636
[TBL] [Abstract][Full Text] [Related]
9. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
Song YH; Cai H; Gu N; Qian CF; Cao SP; Zhao ZM
J Pharm Pharmacol; 2011 Apr; 63(4):541-9. PubMed ID: 21401606
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer.
Cox MJ; Hawkins UA; Hoit BD; Tyagi SC
Circulation; 2004 May; 109(17):2123-8. PubMed ID: 15117845
[TBL] [Abstract][Full Text] [Related]
11. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S
J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015
[TBL] [Abstract][Full Text] [Related]
12. Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients.
Bencsik P; Sasi V; Kiss K; Kupai K; Kolossváry M; Maurovich-Horvat P; Csont T; Ungi I; Merkely B; Ferdinandy P
Eur J Clin Invest; 2015 Jul; 45(7):692-701. PubMed ID: 25944577
[TBL] [Abstract][Full Text] [Related]
13. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
14. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart.
Lalu MM; Pasini E; Schulze CJ; Ferrari-Vivaldi M; Ferrari-Vivaldi G; Bachetti T; Schulz R
Eur Heart J; 2005 Jan; 26(1):27-35. PubMed ID: 15615796
[TBL] [Abstract][Full Text] [Related]
15. Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.
Vianello A; Caponi L; Franzoni F; Galetta F; Rossi M; Taddei M; Malvaldi G; Pietrini P; Santoro G
Clin Sci (Lond); 2009 Jul; 117(4):157-64. PubMed ID: 19196241
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.
Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T
Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238
[TBL] [Abstract][Full Text] [Related]
18. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
[TBL] [Abstract][Full Text] [Related]
19. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
